	Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis. Lancet Kishan AU, Sun Y, Parker CC, Sargos P, Sydes MR, Chabaud S, Brihoum M, Kalbasi TR, Steinberg ML, Valle LF, Taparra K, Shoag JE, Garcia JA, Brown JR, Rettig MB, Singer AE, Reiter RE, Eggener S, Brisbane W, Roy S, Zaorsky NG, Jia AY, Ma TM, Nickols NG, Efstathiou JA, Mohamad O, Dignam JJ, Seiferheld WF, Pollack A, Sandler HM, Nguyen PL, Pommier P, Spratt DE. PMID: 41765025 [PubMed - as supplied by publisher]
	The Hippo pathway in clear cell renal cell carcinoma (ccRCC): a nexus with the VHL disruption? Transl Oncol Waeckel T, Lefranc R, Waeckel M, Riffet M, Tillou X, Levallet G, Bazille C. PMID: 41764979 [PubMed - as supplied by publisher]
	Real-world treatment sequences and overall survival in metastatic bladder cancer: The STATES-Bladder study. Urol Oncol Moinard-Butot F, Barbe-Richaud JB, Baudry E, Pierard L, Amrane K, Maillet D, Barthélémy P. PMID: 41764970 [PubMed - as supplied by publisher]
	A phase II study evaluating pharmacokinetics and dosimetry of (177)Lu-PSMA-617 radioligand therapy in Chinese participants with progressive metastatic castration-resistant prostate cancer. EJNMMI Res Shi H, Guo J, Fan W, Li Y, Huang R, Dong Q, Yang Z, Yang Y, Wang X, Gu D, Huo L, Ji Z, Wang F, Xu D, Jiang Z, Li H, Li J, Li R, Qi L, Wang J, Ye D. PMID: 41764712 [PubMed - as supplied by publisher]
	Regulatory roles of microRNAs in signaling pathways and their biomarker potential in prostate cancer. Cancer Cell Int Kalarestaghi H, Amani N, Shoorei H. PMID: 41764450 [PubMed - as supplied by publisher]
	The impact of different exercise modes on prostate cancer: a Bayesian network meta-analysis. Sci Rep Liu J, Li Q, Han Y. PMID: 41764301 [PubMed - as supplied by publisher]
	Identification of Biomarkers Predictive of Successful Salvage Surgery in Prostate-specific Membrane Antigen Positron Emission Tomography-positive Oligorecurrent Prostate Cancer: Results from the BioPoP Trial. Eur Urol Focus Riethdorf S, Knipper S, Falkenbach F, Coith C, Tilki D, Graefen M, Werner S, Pantel K, Maurer T. PMID: 41763960 [PubMed - as supplied by publisher]
	Cancer Nursing Interventions for Sexual Function and Satisfaction in Men with Prostate Cancer: A Systematic Review and Meta-analysis. Semin Oncol Nurs Birimo, Kerkez M, Bilgin A. PMID: 41763947 [PubMed - as supplied by publisher]
	A Long Noncoding RNA-based Classifier for Identifying More Aggressive Low-grade Ta Bladder Cancer with Elevated FGFR3 Activity. Eur Urol Oncol Thu Phung TA, Weng R, Black PC, Dyrskjøt L, de Jong JJ, Gibb EA. PMID: 41763905 [PubMed - as supplied by publisher]
	Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer. Ann Oncol Gillessen S, Gallardo E, Choudhury A, Saad F, Soares A, Loriot Y, McDermott R, Rodriguez-Vida A, Isaacsson Velho P, Nolè F, Cruz F, Roumeguere T, Daugaard G, Yamamura R, Bompas E, Maroto P, Veiga FG, Skoneczna I, Martins da Trindade K, Mavignier Carcano F, Lecouvet F, Coens C, Poncet C, Fournier B, Tombal B. PMID: 41763609 [PubMed - as supplied by publisher]
	A2AR as a key target for immune microenvironment remodeling in prostate cancer. Transl Oncol Yan L, Yang Z, Zhao X, Chen Y, Wang Z. PMID: 41763068 [PubMed - as supplied by publisher]
	From prostate specific antigen to genomic signatures: Advances in biomarkers for prostate cancer diagnosis and prognosis. Transl Oncol Hamed NW, Elbeljihy HS, Hussin SA, Fouda RM, Oy EK, W Magar R. PMID: 41762538 [PubMed - as supplied by publisher]
	Comparing the national cancer waiting times dataset with other linked electronic health records to measure treatment timeliness: A national cohort study of kidney cancer in England. Cancer Epidemiol Varma R, Mayne E, Parry MA, Nathan A, van der Meulen J, Bahl A, Stewart GD, Cowling TE. PMID: 41762537 [PubMed - as supplied by publisher]
	[(18)F]Fluciclovine PET/CT versus [(18)F]DCFPyL PET/CT in patients with biochemical recurrence of prostate cancer after robot-assisted radical prostatectomy: a prospective, single-center, single-arm, comparative imaging trial. Eur J Nucl Med Mol Imaging Luining WI, Vis AN, Donswijk ML, Koppes JCC, van Leeuwen PJ, Oudshoorn F, Cysouw MCF, Oprea-Lager DE. PMID: 41762267 [PubMed - as supplied by publisher]
	Toward Prostate Cancer Early Warning with a Self-Powered Wearable Biosensing Platform Integrated with Machine Learning. Adv Sci (Weinh) Xu J, Chen H, Yuan Q, Yin L, Tao Y, Wang H, Xue Y, Fu D, Pang H, Chong T, Xue L. PMID: 41761635 [PubMed - as supplied by publisher]
	A trial of risk-adapted prostate cancer screening in a federally supported health center network serving a high-risk population. Cancer Gann PH, Stackhouse N, Gastala N, Ma W, Wright ME, Watson K, Stepping C, King-Lee P, Xu Z, Patel T, Abern MR. PMID: 41761486 [PubMed - in process]
	Therapeutic potential of cytokine-induced killer cell therapy for renal cell carcinoma and prostate cancer. Cell Commun Signal Lee IT, Wang YL, Hong JH, Huang CY, Vo TTT, Lee WJ, Chiang CH. PMID: 41761243 [PubMed - as supplied by publisher]
	A multicenter study on preoperative WHO/ISUP grading of clear cell renal cell carcinoma using triphasic contrast-enhanced CT-based habitat imaging. BMC Med Imaging Zhang L, Shi N, Chen X, Shang S, Lu S, Li T, Liu Y, Han L, Ye J. PMID: 41761150 [PubMed - as supplied by publisher]
	Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial. Nat Med Mellema JJ, Stockem CF, Herberts C, Cheung SK, Vis DJ, van Rhijn BWG, Mertens LS, Boellaard TN, van Montfoort ML, Balduzzi S, de Feijter JM, van der Mijn JCK, Sharma S, El Naggar AC, Boormans JL, Franckena M, Meijer RP, Noteboom JL, Schaake EE, Robbrecht DGJ, Suelmann BBM, van der Heijden MS. PMID: 41760951 [PubMed - as supplied by publisher]
	Real-world treatment patterns and clinical outcomes among patients with metastatic renal cell carcinoma post immune-oncology and vascular endothelial growth factor receptor targeted therapies: A multicenter community oncology-based study. Urol Oncol Shah NJ, Sura S, Shinde R, Dai W, Wentworth C, Conkling P, Bupathi M, Vickery D, Perini R, Motzer RJ. PMID: 41760529 [PubMed - as supplied by publisher]

Articles 1 - 20 / 176371

Page 1 of 8819



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy